Evommune was founded to discover and develop innovative therapies that target key drivers of chronic inflammatory disease.
Our Approach
We use leading edge science to target the root causes of inflammation.
Our Programs
Advancing a pipeline of differentiated product candidates for chronic inflammatory diseases.
Recent News
November 5, 2025
Evommune Announces Pricing of its Initial Public Offering
October 30, 2025